Drug Shortage Report for ESTALIS 250/50 MCG
Report ID | 216175 |
Drug Identification Number | 02241837 |
Brand name | ESTALIS 250/50 MCG |
Common or Proper name | ESTALIS 250/50 MCG |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | NORETHINDRONE ACETATE ESTRADIOL |
Strength(s) | 250MCG 50MCG |
Dosage form(s) | PATCH |
Route of administration | TRANSDERMAL TRANSDERMAL |
Packaging size | 8TTSM |
ATC code | G03FA |
ATC description | PROGESTOGENS AND ESTROGENS IN COMBINATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-01-16 |
Estimated end date | 2024-04-19 |
Actual end date | 2024-04-23 |
Shortage status | Resolved |
Updated date | 2024-04-24 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2024-04-24 | English | Compare |
v9 | 2024-04-23 | French | Compare |
v8 | 2024-04-23 | English | Compare |
v7 | 2024-02-19 | French | Compare |
v6 | 2024-02-19 | English | Compare |
v5 | 2024-01-23 | French | Compare |
v4 | 2024-01-23 | English | Compare |
v3 | 2024-01-17 | English | Compare |
v2 | 2024-01-16 | French | Compare |
v1 | 2024-01-16 | English | Compare |
Showing 1 to 10 of 10